MILAN—Italy will receive around 40,000 doses of Merck & Co.’s COVID-19 antiviral drug next week, which will add to nearly 12,000 already distributed to hospitals, the special COVID-19 commissioner said on Sunday.
“They are intended for clinical cases that risk a serious outcome of the disease,” Commissioner Francesco Figliuolo told a television program on Italy’s RAI 3 channel.
